Quality of life in persons with schizophrenia in out-patient treatment with first- or second-generation antipsychotics

Acta Psychiatrica Scandinavica
Reinhold KilianMatthias C Angermeyer

Abstract

Effects of first in comparison with second-generation antipsychotics on the subjective quality of life (QoL) of patients with schizophrenia under routine treatment conditions were examined. In a prospective naturalistic trial the QoL, social, clinical, and treatment-related characteristics and type of antipsychotic medication of 307 patients with schizophrenia (ICD-10 F 20) were assessed five times with 6-month intervals over 2.5 years. Longitudinal and cross-sectional effects of antipsychotic medication were assessed by hierarchical regression models. Selection bias was controlled by propensity scores. While positive effects of first-generation antipsychotics on subjective QoL in comparison with no antipsychotic treatment were found, second-generation antipsychotics caused no better QoL than first-generation antipsychotics. The hypothesis that second-generation in comparison with first-generation antipsychotics have a better effect on the improvement of subjective QoL of people with schizophrenia in routine out-patient treatment was not supported.

References

Jan 1, 1975·Pharmakopsychiatrie, Neuro-Psychopharmakologie·D J MattkeF L Glötzner
Jun 1, 1990·Archives of General Psychiatry·J K WingN Sartorius
Jul 1, 1990·Schizophrenia Research·D AddingtonB Schissel
May 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·T R Barnes
Jan 1, 1970·Acta Psychiatrica Scandinavica. Supplementum·G M Simpson, J W Angus
Jun 1, 1995·The Journal of Nervous and Mental Disease·C H MillerW W Fleischhacker
Jan 1, 1993·Schizophrenia Bulletin·A G Awad
Mar 1, 1997·The Journal of Nervous and Mental Disease·J RussoD Patrick
May 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·M FranzB Gallhofer
Dec 31, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S H HamiltonC M Beasley
Mar 4, 1998·The Journal of Nervous and Mental Disease·S BrowneE O'Callaghan
Jan 29, 1999·Fortschritte der Neurologie-Psychiatrie·O GruberB Pflug
May 4, 1999·Acta Psychiatrica Scandinavica. Supplementum·J Gerlach, E B Larsen
Jul 17, 1999·Acta Psychiatrica Scandinavica·M DoyleE O'Callaghan
Sep 4, 1999·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·D A RevickiC M Beasley
Feb 2, 2000·European Archives of Psychiatry and Clinical Neuroscience·H Häfner, W an der Heiden
Feb 26, 2000·The International Journal of Social Psychiatry·L HanssonH Vinding
Feb 26, 2000·The International Journal of Social Psychiatry·F Holloway, J Carson
Feb 26, 2000·The International Journal of Social Psychiatry·A G Awad, L N Voruganti
Oct 14, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·P CarrièreT Lempérière
Jan 12, 2001·European Archives of Psychiatry and Clinical Neuroscience·W an der Heiden, H Häfner
Apr 18, 2001·Psychological Medicine·M C AngermeyerS Priebe
Oct 6, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·D Naber, A Karow
Jan 15, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Michael RitsnerIlan Modai
Jan 24, 2002·The Journal of International Medical Research·T Burns, R Bale
Apr 12, 2002·Acta Psychiatrica Scandinavica·L GaiteUNKNOWN EPSILON Study Group
Jun 6, 2002·Schizophrenia Bulletin·Alexander L Miller, Catherine S Craig
Oct 23, 2002·Archives of Disease in Childhood·L Diggle, J Deeks
Dec 26, 2002·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Peter E CookRyan J Van Lieshout
Apr 11, 2003·Statistics in Medicine·Sin-Ho Jung, Chul Ahn
May 1, 1998·European Psychiatry : the Journal of the Association of European Psychiatrists·J BobesA Fernández

❮ Previous
Next ❯

Citations

Aug 13, 2005·Social Psychiatry and Psychiatric Epidemiology·Thomas BeckerUNKNOWN EPSILON Study Group
May 25, 2006·Social Psychiatry and Psychiatric Epidemiology·Katarina Stengler-WenzkeMatthias C Angermeyer
Jun 16, 2010·Psychiatry and Clinical Neurosciences·Takashi NakamaeKenji Fukui
Jun 19, 2013·European Psychiatry : the Journal of the Association of European Psychiatrists·K P HayhurstS W Lewis
Apr 21, 2012·Comprehensive Psychiatry·Xiaofeng GuoUNKNOWN Early-stage Schizophrenia Outcome Study Investigators
Feb 10, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Peter M WehmeierWolfgang Schreiber
Jan 19, 2007·International Journal of Mental Health Nursing·Jeanette Hewitt
Feb 10, 2006·Acta Psychiatrica Scandinavica·A O AdewuyaA B Eegunranti
Jun 14, 2005·Schizophrenia Research·Stephen M StrakowskiUNKNOWN HGDH Research Group
May 3, 2007·The International Journal of Social Psychiatry·Ann M Mortimer, Ahmed Omar Ahmed Al-Agib
Nov 11, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jordi AlonsoDiego Novick
Feb 1, 2005·Expert Review of Pharmacoeconomics & Outcomes Research·Reinhold Kilian, Thomas Becker
Sep 17, 2008·Journal of Clinical Psychopharmacology·Chao-Cheng Lin
Nov 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·Robert E McCueSyed M Hasan
Dec 7, 2007·Schizophrenia Research·Jiri ModestinPuspa Agarwalla

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here